Harald Anderson

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

Anders Widmark, Adalsteinn Gunnlaugsson, L. Beckman et al. · The Lancet · 2019 · 871 citations

Medicine, Radiation Oncology, Urology +16

Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01

Francesco d’Amore, Thomas Relander, Grete F. Lauritzsen et al. · Journal of Clinical Oncology · 2012 · 590 citations

Medicine, Oncology, Cell Therapy +12

Absolute Risk Reductions for Local Recurrence After Postoperative Radiotherapy After Sector Resection for Ductal Carcinoma In Situ of the Breast

Lars Holmberg, Hans Garmo, Bengt Granstrand et al. · Journal of Clinical Oncology · 2008 · 255 citations · Full text

Medicine, Oncology, Surgery +17

Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults

Karin Annertz, Harald Anderson, Anders Biörklund et al. · International Journal of Cancer · 2002 · 242 citations

Medicine, Oncology, Cancer Epidemiology +14

SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening

Stefan O. Emdin, Bengt Granstrand, Anita Ringberg et al. · Acta Oncologica · 2006 · 238 citations · Full text

Medicine, Radiation Oncology, Surgery +17